Karuna Therapeutics launches $400M stock offering
- Karuna Therapeutics (KRTX) on Monday said it commenced an underwritten public offering of $400.0 million of its common stock.
- Karuna also intends to grant the underwriters a 30-day option to purchase an additional $60.0 million of its common stock.
- All the shares in the proposed offering are to be sold by Karuna.
- Goldman Sachs, J.P. Morgan Securities, and Morgan Stanley are acting as joint book-running managers for the offering.
- The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Press Release.
- Shares -3.5% at $176.15 after hours.